Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A44854 | 27056371 | Diabetologia | The liver in focus. | 2016 | Details |
A44861 | 27045003 | Hepatology | Prevalence of nonalcoholic fatty liver disease in the middle eastern area: What is the exact estimation? | 2016 | Details |
A44864 | 27038346 | Hepatology | Errors in meta-analysis on prevalence of nonalcoholic fatty liver disease. | 2016 | Details |
A44887 | 26959309 | Metab Syndr Relat Disord | The Association of Alanine Aminotransferase in Early Pregnancy with Gestational Diabetes. | 2016 | Details |
A44920 | 26790190 | Pharmazie | Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation. | 2015 | Details |
A44934 | 26704864 | J Pediatr Gastroenterol Nutr | Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight. | 2016 | Details |
A44941 | 26664429 | J Res Med Sci | Resveratrol and liver: A systematic review. | 2015 | Details |
A44945 | 26644352 | FASEB J | Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance. | 2015 | Details |
A44969 | 26576484 | J Hepatol | Reply to "The association between sarcopenia and non-alcoholic fatty liver disease: Potential pitfalls in non-invasive prediction models". | 2015 | Details |
A44970 | 26576482 | J Hepatol | The association between sarcopenia and non-alcoholic fatty liver disease: Potential pitfalls in non-invasive prediction models. | 2015 | Details |
A44982 | 26530157 | Am J Physiol Endocrinol Metab | Advances in high-density lipoprotein physiology: surprises, overturns, and promises. | 2015 | Details |
A44995 | 26504484 | Evid Based Complement Alternat Med | Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
A45000 | 26462490 | Dig Dis Sci | Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy. | 2016 | Details |
A45014 | 26442842 | Liver Int | Response to 'Effect of metabolic components on incident type 2 diabetes mellitus in nonalcoholic fatty liver disease subjects'. | 2016 | Details |
A45015 | 26436371 | Ann Hepatol | Nonalcoholic fatty liver disease and polycystic ovary syndrome. | 2016 | Details |
A45016 | 26435214 | Toxicol Appl Pharmacol | Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. | 2015 | Details |
A45027 | 26386359 | Liver Int | Heterogeneity of non-alcoholic fatty liver disease. | 2015 | Details |
A45029 | 26382727 | Dig Liver Dis | Comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. | 2015 | Details |
A45034 | 26374817 | Laeknabladid | [How should obesity be measured in childhood?[Editorial]]. | 2015 | Details |
A45035 | 26364558 | Dig Liver Dis | Authors' reply to the comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. | 2015 | Details |
A45040 | 26343211 | J Clin Lipidol | Combined dyslipidemia in childhood. | 2015 | Details |
A45043 | 26318761 | Pharmacol Res | Similarity between studies of dihydromyricetin and reservatrol for NAFLD. | 2015 | Details |
A45046 | 26302499 | J Clin Gastroenterol | Is Mean Platelet Volume Actually Significantly Higher in Patients With Nonalcoholic Fatty Liver Disease? | 2016 | Details |
A45047 | 26301251 | Biomed Res Int | Krill Oil Ameliorates Mitochondrial Dysfunctions in Rats Treated with High-Fat Diet. | 2015 | Details |
A45048 | 26299475 | Pharmacol Res | Response to letter to the Editor: "Similarity between studies of dihydromyricetin and resveratrol for NAFLD". | 2015 | Details |
A45063 | 26228654 | Liver Transpl | De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients. | 2015 | Details |
A45068 | 26194078 | Endocrinol Metab (Seoul) | Exendin-4 Inhibits the Expression of SEPP1 and Fetuin-A via Improvement of Palmitic Acid-Induced Endoplasmic Reticulum Stress by AMPK. | 2014 | Details |
A45075 | 26167075 | World J Gastroenterol | Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. | 2015 | Details |
A45095 | 26092479 | Life Sci | Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine. | 2015 | Details |
A45099 | 26085100 | J Biol Chem | Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance. | 2015 | Details |
A45119 | 26025313 | Gastroenterology | Gut Serotonin Is a Regulator of Obesity and Metabolism. | 2015 | Details |
A45121 | 26022692 | J Hepatol | Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit? | 2015 | Details |
A45125 | 26009250 | Arch Med Res | Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis. | 2015 | Details |
A45147 | 25916279 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. | 2015 | Details |
A45169 | 25843660 | Nutr Metab Cardiovasc Dis | Iron status in obesity: An independent association with metabolic parameters and effect of weight loss. | 2015 | Details |
A45177 | 25805408 | Trends Endocrinol Metab | Notch signaling as a novel regulator of metabolism. | 2015 | Details |
A45186 | 25774554 | Endocrinology | Vitamin d deficiency attenuates high-fat diet-induced hyperinsulinemia and hepatic lipid accumulation in male mice. | 2015 | Details |
A45189 | 25765160 | Obes Facts | Association of peripheral total and differential leukocyte counts with obesity-related complications in young adults. | 2015 | Details |
A45209 | 25654600 | Nat Med | Reducing peripheral serotonin turns up the heat in brown fat. | 2015 | Details |
A45235 | 25565897 | HIV AIDS (Auckl) | Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. | 2014 | Details |
A45240 | 25564660 | Proc Natl Acad Sci U S A | Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. | 2015 | Details |
A45245 | 25551207 | J Clin Gastroenterol | Evaluation of metabolic syndrome and nonalcoholic steatohepatitis. | 2015 | Details |
A45248 | 27508202 | J Hepatocell Carcinoma | Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma. | 2015 | Details |
A45250 | 25548259 | J Lipid Res | ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content. | 2014 | Details |
A45256 | 25514904 | J Lipid Res | KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression. | 2014 | Details |
A45261 | 25489472 | Ther Adv Endocrinol Metab | Vitamin D insufficiency and insulin resistance in obese adolescents. | 2014 | Details |
A45273 | 25455415 | J Diabetes Complications | A biochemical view: Increase in polyunsaturated fatty acid ω-6/ω-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
A45278 | 25422106 | Diabetes | Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance. | 2014 | Details |
A45293 | 25357150 | J Med Food | Vigna nakashimae extract prevents hepatic steatosis in obese mice fed high-fat diets. | 2014 | Details |
A45294 | 25350520 | Horm Metab Res | Nonalcoholic Fatty liver disease and hyperuricemia: a close relation with hepatic insulin resistance after nicotinic Acid treatment? | 2014 | Details |
A45295 | 25342734 | Diabetes | Ultraviolet radiation suppresses obesity and symptoms of metabolic syndrome independently of vitamin D in mice fed a high-fat diet. | 2014 | Details |
A45300 | 25293340 | Curr Treat Options Cardiovasc Med | Childhood obesity and insulin resistance: how should it be managed? | 2014 | Details |
A45301 | 25287814 | J Nutr Biochem | High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids. | 2014 | Details |
A45309 | 25240528 | Acta Diabetol | Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes. | 2014 | Details |
A45320 | 25198448 | Pediatr Ann | Bariatric surgery in obese adolescents: opportunities and challenges. | 2014 | Details |
A45328 | 25156686 | Metabolism | Leptin treatment: facts and expectations. | 2014 | Details |
A45332 | 25139186 | Digestion | Identifying soluble mediators of nuclear receptor and insulin signaling may enhance noninvasive diagnosis of fibrosis in Fatty liver disease. | 2014 | Details |
A45336 | 25126397 | World J Diabetes | SH2B1 regulation of energy balance, body weight, and glucose metabolism. | 2014 | Details |
A45341 | 25114292 | Diabetes | Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy. | 2014 | Details |
A45342 | 25111132 | JAMA Pediatr | Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity. | 2014 | Details |
A45348 | 25079479 | J Pediatr Gastroenterol Nutr | Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus. | 2015 | Details |
A45349 | 25077735 | Expert Opin Ther Targets | The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target. | 2014 | Details |
A45358 | 25014241 | J Clin Gastroenterol | Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective study. | 2015 | Details |
A45360 | 25004772 | Rev Med Suisse | [Chronic liver diseases and diabetes]. | 2014 | Details |
A45361 | 24993917 | J Nutr Biochem | Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-α and SREBP-1c. | 2014 | Details |
A45369 | 24962189 | Surgery | Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think. | 2014 | Details |
A45390 | 24850543 | Clin Chem Lab Med | Mean platelet volume in patients with non-alcoholic fatty liver disease: is mean platelet volume ready as a surrogate marker? | 2014 | Details |
A45393 | 24828845 | Obesity (Silver Spring) | High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children. | 2014 | Details |
A45401 | 24793205 | J Pediatr | Abnormalities in the growth hormone axis and risk of nonalcoholic steatohepatitis: active player or innocent bystander? | 2014 | Details |
A45409 | 24755648 | J Lipid Res | The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis. | 2014 | Details |
A45415 | 24740831 | Mol Nutr Food Res | The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications. | 2014 | Details |
A45418 | 24727882 | Minerva Med | Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease. | 2014 | Details |
A45426 | 24685365 | Med Hypotheses | Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease. | 2014 | Details |
A45427 | 24680647 | Trends Immunol | The immunomodulating role of exercise in metabolic disease. | 2014 | Details |
A45434 | 24629562 | Metabolism | Obesity-associated mechanisms of hepatocarcinogenesis. | 2014 | Details |
A45437 | 24595352 | Diabetes | Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice. | 2014 | Details |
A45439 | 24582101 | Endocrinol Metab Clin North Am | Relationships between diabetes and cognitive impairment. | 2013 | Details |
A45453 | 24485856 | Diabetes Res Clin Pract | Liver disease and diabetes: association, pathophysiology, and management. | 2014 | Details |
A45468 | 24398583 | Am J Phys Med Rehabil | Multiple factors predict physical performance in people with chronic liver disease. | 2014 | Details |
A45471 | 24396647 | Endocrinol Metab (Seoul) | Association between Serum Albumin, Insulin Resistance, and Incident Diabetes in Nondiabetic Subjects. | 2013 | Details |
A45478 | 24381991 | Am J Respir Crit Care Med | Metabolic complications and obstructive sleep apnea in obese children: time to wake up! | 2014 | Details |
A45484 | 24370846 | Curr Opin Lipidol | Fructose vs. glucose and metabolism: do the metabolic differences matter? | 2014 | Details |
A45486 | 24361124 | Gastroenterology | Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. | 2013 | Details |
A45487 | 24353344 | J Nutr | Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. | 2013 | Details |
A45501 | 24280056 | Endocrinology | Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats. | 2013 | Details |
A45503 | 24274864 | Clin Liver Dis | Adipose tissue as an endocrine organ. | 2014 | Details |
A45509 | 24223615 | Evid Based Complement Alternat Med | Zerumbone, a Natural Cyclic Sesquiterpene of Zingiber zerumbet Smith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat Diet. | 2013 | Details |
A45511 | 24222096 | Semin Liver Dis | Steatohepatitis secondary to long-term glucocorticoid treatment for congenital adrenal hyperplasia: a potential diagnostic pitfall. | 2013 | Details |
A45513 | 24202306 | Arterioscler Thromb Vasc Biol | Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice. | 2013 | Details |
A45520 | 24173291 | Gut | The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62/IGF2BP2-2 as a promoter of NAFLD and HCC? | 2013 | Details |
A45521 | 24170694 | Diabetes | ITCH deficiency protects from diet-induced obesity. | 2013 | Details |
A45522 | 24170613 | Clin Chem | Circulating fetuin-A and risk of ischemic stroke in women. | 2013 | Details |
A45524 | 24143116 | Diabetes Metab Syndr Obes | Hepatic function and the cardiometabolic syndrome. | 2013 | Details |
A45533 | 24095738 | Cell Rep | The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome. | 2013 | Details |
A45539 | 24062606 | J Clin Biochem Nutr | S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism. | 2013 | Details |
A45541 | 24026869 | Curr Diab Rep | What the genetics of lipodystrophy can teach us about insulin resistance and diabetes. | 2013 | Details |
A45545 | 23999826 | Endocr Connect | Increased FGF21 plasma levels in humans with sepsis and SIRS. | 2013 | Details |
A45547 | 23995473 | Diabetologia | Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. | 2013 | Details |
A45551 | 23963894 | Diabetes Care | Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. | 2013 | Details |
A45554 | 23954644 | Clin Gastroenterol Hepatol | Insulin resistance, obesity, and liver cancer. | 2013 | Details |